First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bonkovsky, Herbert
Item TypeName
Concept Ribavirin
Academic Article Outcomes research in chronic viral hepatitis C: effects of interferon therapy.
Academic Article Management of recurrent hepatitis C after liver transplantation: a concise review.
Academic Article Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.
Academic Article Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Academic Article No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
Academic Article Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
Academic Article HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial.
Academic Article Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Academic Article Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
Academic Article Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
Academic Article Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Academic Article Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
Academic Article DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
Academic Article Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.
Academic Article Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.
Academic Article Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Academic Article Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Academic Article Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Academic Article Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Academic Article Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Academic Article Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
Academic Article Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Academic Article An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.
Academic Article Extended interferon-alpha therapy accelerates telomere length loss in human peripheral blood T lymphocytes.
Academic Article YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
Grant HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
Search Criteria
  • Ribavirin